Experimental Two-Step radiation therapy tested in patients with no other options
Disease control
Terminated
This early-phase study tested a new two-step radioactive treatment for people with advanced non-Hodgkin lymphoma that had returned or stopped responding to standard treatments. The goal was to find safe doses and timing for this experimental therapy, which combines a targeting mo…
Phase: PHASE1 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC